Company History

  • 2018

    Expansion

    • Released new opioid free alternatives
    • Established free overnight delivery via UPS
    • Reached a total of 900+ employees
    • Launched a $12.5 million expansion

  • 2017

    Nephron is nationwide

    • Nephron 503B Outsourcing Facility officially launched
    • Became licensed in all 50 states

  • 2016

    Portable relief

    • Budesonide 0.25mg and 0.5mg received ANDA approval
    • National launch of the Pocket Neb

  • 2015

    We're approved

    • After 16 long months, Nephron finally receives full FDA approval

  • 2014

    Nephron moves to South Carolina

    • Nephron headquarters relocated from Orlando, FL to West Columbia, SC
    • Nephron was certified a woman-owned and woman-controlled business by NWBOC (National Women Business Owners Corporation)

  • 2013

    Efficiency through automation

    • The fabrication of the new palletizing systems for the lines at Nephron's South Carolina facility completed

  • 2012

    Relief, now OTC

    • Sodium Chloride (hypertonic saline) 3% and 7% launched
    • Nephron SC breaks ground
    • Launch of our first OTC Medication Asthmanefrin

  • 2011

    A new economic driver for the Midlands

    • Nephron announced that the company would locate its new operations in Lexington County.
    • The $313 million investment is expected to generate 707 new jobs.

  • 2010

    Expanding our reach

    • Abuterol 0.021% Inhalation Solution ANDA approved
    • Nephron expands distribution facilities with the purchase of a warehouse in Phoenix, AZ
    • Murray, KY warehouse expanded to 150,000 sq. ft.

  • 2009

    Fighting for a level playing field

    • Bill Kennedy hearing before the US House of Representatives on H.R. 1706: Protecting Consumer Access to Generic Drugs Act of 2009

  • 2008

    A year of continued growth

    • Manufacturing Facility Expansion: Construction of an additional formulation weigh suite and filling suite
    • Addition of Rommelad BFS Machines to increase capacity by 10 million vials per month

  • 2007

    Improving efficiency and speed

    • Ipratropium Bromide 0.5mg/ Albuterol Sulfate 3mg Inhalation Solution (DuoDose) ANDA approved
    • Addition of a High Speed Single Vial Packaging Line - 35,000 vials per hour
    • Advanced Processes and Quality Controls

  • 2006

    Keeping up with demand

    • Nephron acquires its first pieces of Bosch high-speed packaging machinery

  • 2005

    Automation promotes accuracy

    • Launched the Electronic Fill Weights - EBR Manager

  • 2004

    A breath of fresh air

    • Albuterol 0.042% Inhalation Solution ANDA approved

  • 2003

    Amplifying production

    • Addition of 4 Weiler 640 BFS machines increased capacity to 58 million vials per month

  • 2002

    Getting the word out

    • Lou Kennedy comes on board and begins to build marketing sales force

  • 2001

    Swift growth

    • Albuterol 0.5% Inhalation Solution ANDA approved
    • Ipratropium Bromide 0.02% Inhalation Solution ANDA approved
    • Expansion to 76,000 sq.ft.
    • Addition of single vial, bar coded packaging

  • 2000

    Alleviating respiratory discomfort

    • S2 Racepinephrine Inhalation Solution launched

  • 1999

    Helping patients breathe easy

    • Applied for Alburterol 0.5% Inhalation Solution ANDA

  • 1998

    Outgrowing our space

    • Nephron expanded operations to 56,000 sq. ft.

  • 1997

    Our first product approved

    • Albuterol 0.083% Inhalation Solution ANDA approved